Current Medicinal Chemistry
Volume 26, 42 Issues, 2019
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access
Ranking and Category
-
103th of 293 in
Biochemistry & Molecular Biology
-
16th of 59 in
Chemistry, Medicinal
-
67th of 261 in
Pharmacology & Pharmacy
Contents
Current Medicinal Chemistry, Volume 18 - Number 11
The Endocannabinoid System in the Cancer Therapy: An Overview
, 18(11): 1575 - 1583C. Grimaldi and A. Capasso
DOI: 10.2174/092986711795471374
Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
, 18(11): 1584 - 1598V.T. Labropoulou, A.D. Theocharis, A. Symeonidis, S.S. Skandalis, N.K. Karamanos and H.P. Kalofonos
DOI: 10.2174/092986711795471275
Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
, 18(11): 1599 - 1612A.K. Koutras, I. Starakis, U. Kyriakopoulou, P. Katsaounis, A. Nikolakopoulos and H.P. Kalofonos
DOI: 10.2174/092986711795471338
Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations
, 18(11): 1613 - 1628A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis and S. Murray
DOI: 10.2174/092986711795471383
Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer
, 18(11): 1629 - 1639G. Pentheroudakis and A. Stoyianni
DOI: 10.2174/092986711795471365
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
, 18(11): 1640 - 1650F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni
DOI: 10.2174/092986711795471310
Targeted-Therapy in Advanced Renal Cell Carcinoma
, 18(11): 1651 - 1657M.T. Pirrotta, P. Bernardeschi and G. Fiorentini
DOI: 10.2174/092986711795471293
Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
, 18(11): 1658 - 1671B. Venugopal and T.R.J. Evans
DOI: 10.2174/092986711795471284
Cinnamic Acid Derivatives as Anticancer Agents-A Review
, 18(11): 1672 - 1703P. De, M. Baltas and F. Bedos-Belval
DOI: 10.2174/092986711795471347
Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review
, 18(11): 1704 - 1722R.K. Yadav, S.P. Gupta, P.K. Sharma and V.M. Patil
DOI: 10.2174/092986711795471329
Iron Regulation in Tuberculosis Research: Promise and Challenges
, 18(11): 1723 - 1731A.K. Sharma, R. Naithani, V. Kumar and S.S. Sandhu
DOI: 10.2174/092986711795471301
   |
Editor-in-Chief
Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
About the Journal
⇨ Journal Home⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Author Guidelines⇨ Reviewer Guidelines⇨ Submit Abstracts Online⇨ Submit Manuscripts Online⇨ Thematic Issue Proposal⇨ Editorial Policies⇨ Publishing Ethics and Rectitude⇨ Self-Archiving Policies⇨ Indexing Information⇨ Contents & Abstracts⇨ Special Thematic Issues⇨ Free Copies Online⇨ Purchase Articles⇨ Order Reprints⇨ Subscribe
Quick Links
Webmaster Contact: info@benthamscience.net